Table 1: Patients’
characteristics.
|
Background data |
Patients (n = 14) |
|
Age
(years) |
62.1 ± 7.2 |
|
International
staging system |
|
|
I |
4 |
|
II |
4 |
|
III |
6 |
|
Monoclonal
protein |
|
|
IgG |
10 |
|
IgA |
4 |
|
Concurrent
chemotherapy |
|
|
Absent |
0 |
|
Present |
14 |
|
Months
since diagnosis |
9
[0-396] |
|
Time
between examinations (months) |
9.4 ±
8.6 |
|
Use of
ZA between examinations |
|
|
Absent |
7 |
|
Present |
7 |
|
Response
to chemotherapy |
|
|
CR |
0 |
|
PR (VGPR) |
10 (1) |
|
SD |
3 |
|
PD |
1 |
Data
are presented as means ± SD or median [range], as appropriate. ZA: Zoledronic Acid; CR: Complete Remission; PR: Partial
Response; VGPR: Very Good PR; SD: Stable Disease; PD: Progressive Disease